Related Experiment Video
Updated: May 5, 2026

11:07
High-resolution Optical Mapping of the Mouse Sino-atrial Node
Published on: December 2, 2016
15.7K
Electrophysiological effects of ethmozin on sinus nodal function in patients with and without sinus node dysfunction
European Heart Journal
|March 1, 1984
Summary
Ethmozin prolonged sinus node recovery time (SNRT) in patients with sick sinus syndrome, suggesting caution is needed. This antiarrhythmic drug may increase pauses after tachycardia in these individuals.
Area of Science:
- Electrophysiology
- Cardiology
Background:
- Sick sinus syndrome (SSS) is a common cause of bradycardia.
- Sinus node dysfunction affects heart rate regulation.
- Ethmozin is an antiarrhythmic drug with potential effects on cardiac electrical activity.
Purpose of the Study:
- To investigate the electrophysiological effects of ethmozin on sinus node function.
- To assess the impact of ethmozin on sinus node recovery time (SNRT) in patients with and without SSS.
Main Methods:
- Intravenous administration of ethmozin (1 mg/kg) to 32 patients.
- Patients were divided into Group A (SSS, SNRT > 1500 ms) and Group B (normal SNRT).
- Electrophysiological parameters, including SNRT and sinoatrial conduction time, were measured.
Main Results:
- Ethmozin did not significantly alter mean sinus cycle length in either group.
- SNRT was significantly prolonged by ethmozin in Group A (SSS patients).
- Corrected SNRT showed a more pronounced increase in Group A compared to Group B.
Conclusions:
- Ethmozin administration can prolong SNRT in patients with sick sinus syndrome.
- The drug may increase the duration of post-tachycardia pauses in individuals with SSS.
- Caution is advised when administering ethmozin to patients exhibiting signs of sinus node dysfunction.
Related Concept Videos
Electrophysiology of Normal Cardiac Rhythm
7.8K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
7.8K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
4.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
4.2K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
2.9K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
Heart Failure Drugs: Inotropic Agents
2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
Antiepileptic Drugs: Potassium Channel Activators
1.0K
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
1.0K
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
1.2K
Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
1.2K

